116 related articles for article (PubMed ID: 2925277)
1. Over-expression of MDR1 gene with no DNA amplification in a multiple-drug-resistant human ovarian carcinoma cell line.
Bénard J; Da Silva J; Teyssier JR; Riou G
Int J Cancer; 1989 Mar; 43(3):471-7. PubMed ID: 2925277
[TBL] [Abstract][Full Text] [Related]
2. Drug-related chromosomal changes in chemoresistant human ovarian carcinoma cells.
Teyssier JR; Bénard J; Ferre D; Da Silva J; Renaud L
Cancer Genet Cytogenet; 1989 May; 39(1):35-43. PubMed ID: 2731146
[TBL] [Abstract][Full Text] [Related]
3. [The relationship between multi-drug resistance gene expression and drug resistance of ovarian carcinoma].
Zhu L; Lang J; Shen K
Zhonghua Fu Chan Ke Za Zhi; 1997 Aug; 32(8):462-6. PubMed ID: 9639738
[TBL] [Abstract][Full Text] [Related]
4. Relationship between expression of P-glycoprotein and efficacy of trifluoperazine in multidrug-resistant cells.
Ganapathi R; Kuo T; Teeter L; Grabowski D; Ford J
Mol Pharmacol; 1991 Jan; 39(1):1-8. PubMed ID: 1670962
[TBL] [Abstract][Full Text] [Related]
5. Differential modulation of nuclear texture, histone acetylation, and MDR1 gene expression in human drug-sensitive and -resistant OV1 cell lines.
Yatouji S; El-Khoury V; Trentesaux C; Trussardi-Regnier A; Benabid R; Bontems F; Dufer J
Int J Oncol; 2007 Apr; 30(4):1003-9. PubMed ID: 17332941
[TBL] [Abstract][Full Text] [Related]
6. Differential expression of steroid receptors, hsp27, and pS2 in a series of drug resistant human breast tumor cell lines derived following exposure to antitumor drugs or to fractionated X-irradiation.
Whelan RD; Hill BT
Breast Cancer Res Treat; 1993; 26(1):23-39. PubMed ID: 8400321
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of vincristine cytotoxicity in drug-resistant cells by simultaneous treatment with onconase, an antitumor ribonuclease.
Rybak SM; Pearson JW; Fogler WE; Volker K; Spence SE; Newton DL; Mikulski SM; Ardelt W; Riggs CW; Kung HF; Longo DL
J Natl Cancer Inst; 1996 Jun; 88(11):747-53. PubMed ID: 8637029
[TBL] [Abstract][Full Text] [Related]
8. Doxorubicin-resistant variants of human prostate cancer cell lines DU 145, PC-3, PPC-1, and TSU-PR1: characterization of biochemical determinants of antineoplastic drug sensitivity.
David-Beabes GL; Overman MJ; Petrofski JA; Campbell PA; de Marzo AM; Nelson WG
Int J Oncol; 2000 Dec; 17(6):1077-86. PubMed ID: 11078791
[TBL] [Abstract][Full Text] [Related]
9. Characterization of four doxorubicin adapted human breast cancer cell lines with respect to chemotherapeutic drug sensitivity, drug resistance associated membrane proteins and glutathione transferases.
de la Torre M; Hao XY; Larsson R; Nygren P; Tsuruo T; Mannervik B; Bergh J
Anticancer Res; 1993; 13(5A):1425-30. PubMed ID: 7902062
[TBL] [Abstract][Full Text] [Related]
10. Potentiation of etoposide and vincristine by two synthetic 1,4-dihydropyridine derivatives in multidrug-resistant and atypical multidrug-resistant human cancer cells.
Watanabe Y; Takano H; Kiue A; Kohno K; Kuwano M
Anticancer Drug Des; 1991 Feb; 6(1):47-57. PubMed ID: 2015041
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of vincristine- and adriamycin-induced cytotoxicity by verapamil in P388 leukemia and its sublines resistant to vincristine and adriamycin.
Tsuruo T; Iida H; Yamashiro M; Tsukagoshi S; Sakurai Y
Biochem Pharmacol; 1982 Oct; 31(19):3138-40. PubMed ID: 7150340
[TBL] [Abstract][Full Text] [Related]
12. Doxorubicin, vincristine, and actinomycin-D, but not teniposide, require long-lasting uninterrupted verapamil pressure to overcome drug resistance in multidrug-resistant cells.
Toffoli G; Tumiotto L; Gigante M; Perin T; Biscontin G; Boiocchi M
Cancer Detect Prev; 1993; 17(3):425-32. PubMed ID: 8402730
[TBL] [Abstract][Full Text] [Related]
13. Ascorbic acid increases drug accumulation and reverses vincristine resistance of human non-small-cell lung-cancer cells.
Chiang CD; Song EJ; Yang VC; Chao CC
Biochem J; 1994 Aug; 301 ( Pt 3)(Pt 3):759-64. PubMed ID: 7914401
[TBL] [Abstract][Full Text] [Related]
14. Acquired vs innate multidrug resistance and the effect of calcium channel blockers.
Tsuruo T
Prog Clin Biol Res; 1986; 223():203-16. PubMed ID: 3468516
[TBL] [Abstract][Full Text] [Related]
15. Mitomycin C cross-resistance induced by adriamycin in human ovarian cancer cells in vitro.
Mizuno K; Furuhashi Y; Maeda O; Iwata M; Misawa T; Kawai M; Kano T; Tomoda Y
Cancer Chemother Pharmacol; 1990; 26(5):333-9. PubMed ID: 1976451
[TBL] [Abstract][Full Text] [Related]
16. Differential increases in glutathione S-transferase activities in a range of multidrug-resistant human tumor cell lines.
Whelan RD; Hosking LK; Townsend AJ; Cowan KH; Hill BT
Cancer Commun; 1989; 1(6):359-65. PubMed ID: 2702041
[TBL] [Abstract][Full Text] [Related]
17. Differential in vitro sensitivity of human tumor and normal cells to chemotherapeutic agents and resistance modulators.
Nygren P; Larsson R
Int J Cancer; 1991 Jun; 48(4):598-604. PubMed ID: 2045203
[TBL] [Abstract][Full Text] [Related]
18. Pleiotropic-resistant phenotype is a multifactorial phenomenon in human colon carcinoma cell lines.
Toffoli G; Viel A; Tumiotto L; Biscontin G; Rossi C; Boiocchi M
Br J Cancer; 1991 Jan; 63(1):51-6. PubMed ID: 1671208
[TBL] [Abstract][Full Text] [Related]
19. Vincristine-resistant human leukemia cell line: new monoclonal antibodies to a 65kDa membrane protein.
Kakihara T; Yamada T; Fukuda T; Ohnishi Y; Kishi K; Shibata A
Leuk Lymphoma; 1992 May; 7(1-2):157-64. PubMed ID: 1472928
[TBL] [Abstract][Full Text] [Related]
20. Characterization of newly established human myeloid leukemia cell line (KF-19) and its drug resistant sublines.
Fukuda T; Kamishima T; Kakihara T; Ohnishi Y; Suzuki T
Leuk Res; 1996; 20(11-12):931-9. PubMed ID: 9009251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
